Harmony Biosciences Holdings (HRMY) Common Equity (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Common Equity of $999.24 million for Q2 2026, up 29.3% from $773.08 million a year earlier and up 9.8% from the prior quarter.
Harmony Biosciences Holdings (HRMY) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Harmony Biosciences Holdings posted Common Equity of $870.22 million, up 32.0% from FY2024.
- Common Equity has increased for five consecutive years, with a five-year compound annual growth rate of 55.0% (FY2020 to FY2025).
- By year, Common Equity came in at $659.16 million in FY2024 (+41.1%), $466.99 million in FY2023 (+15.9%), $402.84 million in FY2022 (+116.0%) and $186.51 million in FY2021 (+91.9%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q3 2019.
- Year over year, Common Equity has now increased in each of the last 20 quarters, with growth averaging 34.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Common Equity ran from 11.0% in Q2 2024 to 126.2% in Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $910.35 million (Q1 2026), $870.22 million (Q4 2025) and $835.12 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -473.07 Mn | 198.08 Mn | 999.24 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 999.24 Mn |
| Mar 31, 2026 | 910.35 Mn |
| Dec 31, 2025 | 870.22 Mn |
| Sep 30, 2025 | 835.12 Mn |
| Jun 30, 2025 | 773.08 Mn |
| Mar 31, 2025 | 720.53 Mn |
| Dec 31, 2024 | 659.16 Mn |
| Sep 30, 2024 | 596.80 Mn |
| Jun 30, 2024 | 538.58 Mn |
| Mar 31, 2024 | 515.39 Mn |
| Dec 31, 2023 | 466.99 Mn |
| Sep 30, 2023 | 481.33 Mn |
| Jun 30, 2023 | 485.17 Mn |
| Mar 31, 2023 | 443.04 Mn |
| Dec 31, 2022 | 402.84 Mn |
| Sep 30, 2022 | 343.88 Mn |
| Jun 30, 2022 | 246.53 Mn |
| Mar 31, 2022 | 214.50 Mn |
| Dec 31, 2021 | 186.51 Mn |
| Sep 30, 2021 | 152.02 Mn |
Harmony Biosciences Holdings Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=HRMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();